US Stock MarketDetailed Quotes

Jaguar Health (JAGX)

Watchlist
  • 3.050
  • +0.130+4.45%
Close Jun 4 16:00 ET
  • 2.860
  • -0.190-6.23%
Pre 04:34 ET
2.20MMarket Cap-0.02P/E (TTM)

Jaguar Health (JAGX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
220.73%8.83M
19.39%-23.69M
29.87%-5.49M
26.05%-4.69M
24.17%-6.2M
-3.79%-7.31M
11.61%-29.38M
-5.03%-7.83M
6.61%-6.34M
9.78%-8.17M
Net income from continuing operations
176.12%8.27M
-39.39%-54.41M
-132.39%-23.19M
3.97%-9.78M
-8.87%-10.58M
-18.65%-10.86M
6.77%-39.03M
-9.09%-9.98M
-27.52%-10.19M
19.71%-9.72M
Operating gains losses
1,830.30%637K
277.15%1.96M
-68.33%19K
40.63%45K
6,113.33%1.86M
102.69%33K
69.64%-1.11M
566.67%60K
100.87%32K
400.00%30K
Depreciation and amortization
-4.76%520K
-6.62%2.2M
-8.43%543K
-6.54%557K
-0.54%556K
-10.49%546K
-1.26%2.36M
0.34%593K
-4.64%596K
-9.98%559K
Other non cash items
--257K
-45.94%153K
----
----
----
----
-97.88%283K
--0
--0
-99.71%9K
Change In working capital
-201.51%-1.34M
648.47%16.51M
970.19%12.52M
1,248.88%2.05M
150.08%621K
963.40%1.32M
72.88%-3.01M
56.76%-1.44M
96.82%-178K
37.91%-1.24M
-Change in receivables
446.72%1.42M
-107.41%-39K
45.45%-192K
-393.75%-188K
-76.50%82K
-44.30%259K
76.51%526K
-8.64%-352K
121.62%64K
411.61%349K
-Change in inventory
473.21%780K
78.03%-254K
104.32%29K
177.12%91K
69.22%-165K
-223.67%-209K
46.61%-1.16M
17.16%-671K
-2.61%-118K
-227.62%-536K
-Change in prepaid assets
147.43%231K
805.22%10.67M
5,967.89%11.53M
-108.73%-84K
81.16%-288K
57.13%-487K
69.81%-1.51M
107.95%190K
-17.64%962K
57.86%-1.53M
-Change in payables and accrued expense
-299.25%-3.71M
772.73%5.4M
144.04%196K
1,536.36%2.34M
59.55%1M
265.10%1.86M
78.92%-803K
-254.51%-445K
102.30%143K
-56.48%628K
-Change in other current assets
--37K
449.11%1.17M
21,400.00%1.07M
100.19%2K
10,500.00%106K
--0
-1,876.47%-336K
-266.67%-5K
-26,575.00%-1.07M
-50.00%1K
-Change in other current liabilities
22.22%-49K
39.69%-272K
45.61%-62K
38.66%-73K
33.33%-74K
41.12%-63K
-14.47%-451K
-21.28%-114K
4.80%-119K
9.02%-111K
-Change in other working capital
2.33%-42K
-123.65%-171K
-2.38%-43K
0.00%-43K
0.00%-42K
-105.06%-43K
--723K
---42K
---43K
---42K
Cash from discontinued investing activities
Operating cash flow
220.73%8.83M
19.39%-23.69M
29.87%-5.49M
26.05%-4.69M
24.17%-6.2M
-3.79%-7.31M
11.61%-29.38M
-5.03%-7.83M
6.61%-6.34M
9.78%-8.17M
Investing cash flow
Cash flow from continuing investing activities
82.25%-41K
106.05%13K
-54K
-231K
-215K
0
Net PPE purchase and sale
----
-156.25%-41K
--13K
---54K
----
----
---16K
--0
--0
----
Net intangibles purchase and sale
----
--0
----
----
----
----
---215K
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
82.25%-41K
106.05%13K
---54K
----
----
---231K
---215K
--0
----
Financing cash flow
Cash flow from continuing financing activities
-233.21%-6.62M
-24.14%23.67M
245.94%9.79M
77.31%6.26M
-78.89%2.66M
-59.52%4.97M
-8.84%31.2M
-73.43%2.83M
150.53%3.53M
274.56%12.57M
Net issuance payments of debt
-306.07%-6.62M
1,892.80%12.69M
5,848.54%9.83M
9.95%-199K
-57.45%-148K
1,545.95%3.21M
25.71%-708K
71.97%-171K
---221K
-64.91%-94K
Net common stock issuance
--0
-73.05%8.6M
-101.33%-40K
43.70%5.39M
-88.21%1.49M
-85.94%1.76M
-0.59%31.91M
-73.33%3M
162.49%3.75M
715.71%12.67M
Net preferred stock issuance
----
--2.38M
--0
--1.07M
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
--0
--0
----
Net other financing activities
---180K
-7.24%-652K
0.58%-170K
----
----
----
-149.31%-608K
-2,950.00%-171K
----
----
Cash from discontinued financing activities
Financing cash flow
-233.21%-6.62M
-24.14%23.67M
245.94%9.79M
77.31%6.26M
-78.89%2.66M
-59.52%4.97M
-8.84%31.2M
-73.43%2.83M
150.53%3.53M
274.56%12.57M
Net cash flow
Beginning cash position
-2.12%7.83M
23.70%8M
-73.42%3.53M
-86.25%2.21M
-51.25%5.69M
23.70%8M
18.28%6.47M
311.31%13.27M
86.03%16.05M
-18.77%11.67M
Current changes in cash
194.34%2.22M
-103.59%-57K
182.81%4.32M
153.93%1.52M
-180.67%-3.54M
-144.97%-2.35M
61.12%1.59M
-262.89%-5.21M
47.76%-2.81M
177.00%4.39M
Effect of exchange rate changes
-52.78%17K
-109.26%-113K
82.14%-10K
-732.26%-196K
670.00%57K
289.47%36K
-460.00%-54K
-227.27%-56K
255.00%31K
75.61%-10K
End cash Position
76.87%10.06M
-2.12%7.83M
-2.12%7.83M
-73.42%3.53M
-86.25%2.21M
-51.25%5.69M
23.70%8M
23.70%8M
311.31%13.27M
86.03%16.05M
Free cash flow
220.73%8.83M
19.88%-23.73M
31.91%-5.48M
25.20%-4.74M
24.32%-6.2M
-3.79%-7.31M
10.91%-29.62M
-7.92%-8.04M
6.61%-6.34M
9.61%-8.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 220.73%8.83M19.39%-23.69M29.87%-5.49M26.05%-4.69M24.17%-6.2M-3.79%-7.31M11.61%-29.38M-5.03%-7.83M6.61%-6.34M9.78%-8.17M
Net income from continuing operations 176.12%8.27M-39.39%-54.41M-132.39%-23.19M3.97%-9.78M-8.87%-10.58M-18.65%-10.86M6.77%-39.03M-9.09%-9.98M-27.52%-10.19M19.71%-9.72M
Operating gains losses 1,830.30%637K277.15%1.96M-68.33%19K40.63%45K6,113.33%1.86M102.69%33K69.64%-1.11M566.67%60K100.87%32K400.00%30K
Depreciation and amortization -4.76%520K-6.62%2.2M-8.43%543K-6.54%557K-0.54%556K-10.49%546K-1.26%2.36M0.34%593K-4.64%596K-9.98%559K
Other non cash items --257K-45.94%153K-----------------97.88%283K--0--0-99.71%9K
Change In working capital -201.51%-1.34M648.47%16.51M970.19%12.52M1,248.88%2.05M150.08%621K963.40%1.32M72.88%-3.01M56.76%-1.44M96.82%-178K37.91%-1.24M
-Change in receivables 446.72%1.42M-107.41%-39K45.45%-192K-393.75%-188K-76.50%82K-44.30%259K76.51%526K-8.64%-352K121.62%64K411.61%349K
-Change in inventory 473.21%780K78.03%-254K104.32%29K177.12%91K69.22%-165K-223.67%-209K46.61%-1.16M17.16%-671K-2.61%-118K-227.62%-536K
-Change in prepaid assets 147.43%231K805.22%10.67M5,967.89%11.53M-108.73%-84K81.16%-288K57.13%-487K69.81%-1.51M107.95%190K-17.64%962K57.86%-1.53M
-Change in payables and accrued expense -299.25%-3.71M772.73%5.4M144.04%196K1,536.36%2.34M59.55%1M265.10%1.86M78.92%-803K-254.51%-445K102.30%143K-56.48%628K
-Change in other current assets --37K449.11%1.17M21,400.00%1.07M100.19%2K10,500.00%106K--0-1,876.47%-336K-266.67%-5K-26,575.00%-1.07M-50.00%1K
-Change in other current liabilities 22.22%-49K39.69%-272K45.61%-62K38.66%-73K33.33%-74K41.12%-63K-14.47%-451K-21.28%-114K4.80%-119K9.02%-111K
-Change in other working capital 2.33%-42K-123.65%-171K-2.38%-43K0.00%-43K0.00%-42K-105.06%-43K--723K---42K---43K---42K
Cash from discontinued investing activities
Operating cash flow 220.73%8.83M19.39%-23.69M29.87%-5.49M26.05%-4.69M24.17%-6.2M-3.79%-7.31M11.61%-29.38M-5.03%-7.83M6.61%-6.34M9.78%-8.17M
Investing cash flow
Cash flow from continuing investing activities 82.25%-41K106.05%13K-54K-231K-215K0
Net PPE purchase and sale -----156.25%-41K--13K---54K-----------16K--0--0----
Net intangibles purchase and sale ------0-------------------215K------------
Cash from discontinued investing activities
Investing cash flow ----82.25%-41K106.05%13K---54K-----------231K---215K--0----
Financing cash flow
Cash flow from continuing financing activities -233.21%-6.62M-24.14%23.67M245.94%9.79M77.31%6.26M-78.89%2.66M-59.52%4.97M-8.84%31.2M-73.43%2.83M150.53%3.53M274.56%12.57M
Net issuance payments of debt -306.07%-6.62M1,892.80%12.69M5,848.54%9.83M9.95%-199K-57.45%-148K1,545.95%3.21M25.71%-708K71.97%-171K---221K-64.91%-94K
Net common stock issuance --0-73.05%8.6M-101.33%-40K43.70%5.39M-88.21%1.49M-85.94%1.76M-0.59%31.91M-73.33%3M162.49%3.75M715.71%12.67M
Net preferred stock issuance ------2.38M--0--1.07M----------0--0--0----
Proceeds from stock option exercised by employees --------------------------0--0--0----
Net other financing activities ---180K-7.24%-652K0.58%-170K-------------149.31%-608K-2,950.00%-171K--------
Cash from discontinued financing activities
Financing cash flow -233.21%-6.62M-24.14%23.67M245.94%9.79M77.31%6.26M-78.89%2.66M-59.52%4.97M-8.84%31.2M-73.43%2.83M150.53%3.53M274.56%12.57M
Net cash flow
Beginning cash position -2.12%7.83M23.70%8M-73.42%3.53M-86.25%2.21M-51.25%5.69M23.70%8M18.28%6.47M311.31%13.27M86.03%16.05M-18.77%11.67M
Current changes in cash 194.34%2.22M-103.59%-57K182.81%4.32M153.93%1.52M-180.67%-3.54M-144.97%-2.35M61.12%1.59M-262.89%-5.21M47.76%-2.81M177.00%4.39M
Effect of exchange rate changes -52.78%17K-109.26%-113K82.14%-10K-732.26%-196K670.00%57K289.47%36K-460.00%-54K-227.27%-56K255.00%31K75.61%-10K
End cash Position 76.87%10.06M-2.12%7.83M-2.12%7.83M-73.42%3.53M-86.25%2.21M-51.25%5.69M23.70%8M23.70%8M311.31%13.27M86.03%16.05M
Free cash flow 220.73%8.83M19.88%-23.73M31.91%-5.48M25.20%-4.74M24.32%-6.2M-3.79%-7.31M10.91%-29.62M-7.92%-8.04M6.61%-6.34M9.61%-8.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More